Verve Therapeutics
Bharathi is an analyst II, quality control at Verve Therapeutics. Prior to joining Verve, Bharathi worked as a process development associate at the Broad Institute, genomics platform, in COVID-19 diagnostics and genomic sequencing operations. While there, she developed and validated NGS technology for a stealth mode sequencing startup. She has a B.S. degree in nutritional sciences from University of California, Davis and M.S. degrees in public health nutrition and biomedical sciences from Boston University.
This person is not in the org chart
This person is not in any offices
Verve Therapeutics
59 followers
Verve Therapeutics is a biotechnology company focused on discovering and developing therapies that safely edit the genomes of adults to confer lifelong protection against coronary artery disease, the most common type of heart disease and the leading cause of death worldwide.